41
Participants
Start Date
June 30, 2015
Primary Completion Date
March 31, 2016
Study Completion Date
June 30, 2016
PA101
40 mg PA101 administered via inhalation three times daily for 6 weeks
Placebo
matching placebo administered via inhalation three times daily for 6 weeks
Hopital Necker - Enfants Malades, Paris
Charité - Universitätsmedizin Berlin, Berlin
Klinikum Darmstadt, Darmstadt
University Medical Center Mainz, Mainz
Technical University München, Munich
University of Salerno, Salerno
University Medical Center of Groningen, Groningen
Hospital Universitario de Fuenlabrada, Madrid
Lead Sponsor
Patara Pharma
INDUSTRY